Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection
Authors
Keywords
-
Journal
npj Vaccines
Volume 5, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-06
DOI
10.1038/s41541-020-0205-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody responses to yellow fever vaccine in 9 to 11-month-old Malian and Ghanaian children
- (2019) Olubukola T. Idoko et al. Expert Review of Vaccines
- Differences between coverage of yellow fever vaccine and the first dose of measles-containing vaccine: A desk review of global data sources
- (2019) Nedghie Adrien et al. VACCINE
- Yellow Fever Vaccine: The Conundrum of 2 Doses, One Dose, or One-Fifth Dose to Induce and Maintain Protective Immunity
- (2019) Alan D T Barrett JOURNAL OF INFECTIOUS DISEASES
- Long-term immunity against yellow fever in children vaccinated during infancy: a longitudinal cohort study
- (2019) Cristina Domingo et al. LANCET INFECTIOUS DISEASES
- Are booster doses of yellow fever vaccine needed?
- (2019) Pedro F C Vasconcelos et al. LANCET INFECTIOUS DISEASES
- Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children
- (2019) Ana Carolina Campi-Azevedo et al. Frontiers in Immunology
- Duration of post-vaccination humoral immunity against yellow fever in children
- (2019) Tatiana Guimarães de Noronha et al. VACCINE
- Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak — Preliminary Report
- (2018) Steve Ahuka-Mundeke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health security's blind spot
- (2018) Seth Berkley SCIENCE
- Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study
- (2018) Reinaldo de Menezes Martins et al. VACCINE
- Persistence of Yellow fever virus outside the Amazon Basin, causing epidemics in Southeast Brazil, from 2016 to 2018
- (2018) Izabela Maurício de Rezende et al. PLoS Neglected Tropical Diseases
- Long-Term Protection After Fractional-Dose Yellow Fever Vaccination
- (2018) Anna H.E. Roukens et al. ANNALS OF INTERNAL MEDICINE
- Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis
- (2017) Freya M Shearer et al. LANCET INFECTIOUS DISEASES
- Single shot of 17D vaccine may not confer life-long protection against yellow fever
- (2017) Pedro FC Vasconcelos MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
- (2017) Karina Takesaki Miyaji et al. REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
- Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination
- (2017) Michael Kongsgaard et al. Scientific Reports
- Questions regarding the safety and duration of immunity following live yellow fever vaccination
- (2016) Ian J. Amanna et al. Expert Review of Vaccines
- 17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients
- (2016) R.W. Wieten et al. JOURNAL OF INFECTION
- Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) When Administered Concomitantly With a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12–13 Months of Age in Colombia and Peru
- (2016) Pio López et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination
- (2016) Rosanne W. Wieten et al. PLoS One
- Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali
- (2015) Panchali Roy Chowdhury et al. CLINICAL INFECTIOUS DISEASES
- Immune activation alters cellular and humoral responses to yellow fever 17D vaccine
- (2014) Enoch Muyanja et al. JOURNAL OF CLINICAL INVESTIGATION
- The whole iceberg: estimating the incidence of yellow fever virus infection from the number of severe cases
- (2014) Michael A. Johansson et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years
- (2013) Eduardo Gotuzzo et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Yellow fever revaccination guidelines change – a decision too feverish?
- (2013) M.P. Grobusch et al. CLINICAL MICROBIOLOGY AND INFECTION
- Historical analysis of the records of sylvan yellow fever in the State of Amazonas, Brazil, from 1996 to 2009
- (2013) Maria das Graças Gomes Saraiva et al. Revista da Sociedade Brasileira de Medicina Tropical
- Demographic profile of sylvatic yellow fever in Brazil from 1973 to 2008
- (2013) F. P. Camara et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- 17DD yellow fever vaccine
- (2013) Reinaldo M. Martins et al. Human Vaccines & Immunotherapeutics
- Detection of Anti-Yellow Fever Virus Immunoglobulin M Antibodies at 3–4 Years Following Yellow Fever Vaccination
- (2012) Katherine B. Gibney et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Incubation Periods of Yellow Fever Virus
- (2010) Michael A. Johansson et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Safety of 17D derived yellow fever vaccines
- (2009) Cristina Domingo et al. Expert Opinion On Drug Safety
- Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses
- (2008) John T. Roehrig et al. VIRAL IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started